#mrna-covid-19-vaccines

[ follow ]
#patent-dispute-settlement #lipid-nanoparticle-technology #moderna-licensing #vaers #vaccine-safety
Intellectual property law
fromMedCity News
1 week ago

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology - MedCity News

Moderna settles a patent dispute with Arbutus Biopharma and Genevant Sciences for $950 million upfront plus potentially over $1 billion more, acknowledging their lipid nanoparticle technology's role in Covid-19 vaccine development.
fromArs Technica
6 months ago

RFK Jr.'s CDC may limit COVID shots to 75 and up, claim they killed kids

Four unnamed sources close to the situation told the Post that Trump administration health officials appear to be using information from the Vaccine Adverse Event Reporting System (VAERS) to make the claim that COVID-19 vaccines have killed children. VAERS is a system in which anyone can report anything they think is an adverse event related to a vaccination.
Public health
[ Load more ]